# SeqOnce BioSciences, Inc. — Form D

SeqOnce BioSciences, Inc. of PASADENA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-27. The offering totals $1.2M, of which $1.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-04-27
- Form: D
- Accession: 0001655808-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $1.0M
- Remaining: $210K
- Investors: 12
- Date of first sale: 2018-04-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-311199

## Issuer

- Name: SeqOnce BioSciences, Inc.
- CIK: 0001655808
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 2265 E. FOOTHILL BOULEVARD, PASADENA, CA, 91107
- Phone: 626-765-3894

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Michael Giardello | Director | Pasadena, CA |
| Christopher Angermayer | Director | Pasadena, CA |
| Christopher Angermayer | Executive Officer | Pasadena, CA |
| Joseph Dunham | Director | Pasadena, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-11-05](https://search.stillhousedata.com/formd/0001655808-24-000001) | D | $882K | $882K |

## More

- [CIK 1655808 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1655808&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001655808-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.